Transfusion Therapy in Sickle Cell Disease

K. Akaba, B. Bassey, I. Akpan, Ofonimeh E Effiong
{"title":"Transfusion Therapy in Sickle Cell Disease","authors":"K. Akaba, B. Bassey, I. Akpan, Ofonimeh E Effiong","doi":"10.37421/JBL.2019.9.244","DOIUrl":null,"url":null,"abstract":"Background: Blood transfusion is an important therapy in the management of sickle cell disease (SCD); especially in developing countries. Transfusion aids the restoration of the oxygen carrying capacity in patients with SCD and also prevents vaso-occlusion by dilution of the Hbs in circulation. However, there is paucity of information on transfusion as a therapy in the management of SCD. Aim and objective: This study is aimed at reviewing the available publications on transfusion as a therapy for SCD management. Materials and methods: Relevant literatures were searched on databases including PubMed, Google Scholar, Scopus, Cochrane and standard texts on haematology and transfusion medicine. The keywords used in the search are sickle cell disease, transfusion, simple and chronic transfusion, complications of transfusion, choice of blood for transfusion and guidelines for blood transfusion. The literatures gathered were reviewed, summarized and presented in this review. Results: Blood transfusion is a cornerstone in the management of patients with SCD. The management of SCD patients requires a multidisciplinary approach with a great deal of commitment been required from all the experts. Although, many hazards are associated with blood transfusion, it is pertinent that proper care is taken in the handling and administration of blood and blood products. Conclusion: Transfusion therapy still remains a cornerstone in SCD management and it tends to mitigate the severity and complication associated with SCD disorders. Adequate knowledge and information is needed by experts on the importance of transfusion therapy and its modalities in SCD.","PeriodicalId":90886,"journal":{"name":"Journal of blood & lymph","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of blood & lymph","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37421/JBL.2019.9.244","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Blood transfusion is an important therapy in the management of sickle cell disease (SCD); especially in developing countries. Transfusion aids the restoration of the oxygen carrying capacity in patients with SCD and also prevents vaso-occlusion by dilution of the Hbs in circulation. However, there is paucity of information on transfusion as a therapy in the management of SCD. Aim and objective: This study is aimed at reviewing the available publications on transfusion as a therapy for SCD management. Materials and methods: Relevant literatures were searched on databases including PubMed, Google Scholar, Scopus, Cochrane and standard texts on haematology and transfusion medicine. The keywords used in the search are sickle cell disease, transfusion, simple and chronic transfusion, complications of transfusion, choice of blood for transfusion and guidelines for blood transfusion. The literatures gathered were reviewed, summarized and presented in this review. Results: Blood transfusion is a cornerstone in the management of patients with SCD. The management of SCD patients requires a multidisciplinary approach with a great deal of commitment been required from all the experts. Although, many hazards are associated with blood transfusion, it is pertinent that proper care is taken in the handling and administration of blood and blood products. Conclusion: Transfusion therapy still remains a cornerstone in SCD management and it tends to mitigate the severity and complication associated with SCD disorders. Adequate knowledge and information is needed by experts on the importance of transfusion therapy and its modalities in SCD.
镰状细胞病的输血治疗
背景:输血是治疗镰状细胞病(SCD)的重要方法;尤其是在发展中国家。输血有助于恢复SCD患者的携氧能力,并通过稀释循环中的Hbs来防止血管闭塞。然而,关于输血作为一种治疗SCD的信息缺乏。目的和目的:本研究旨在回顾现有的关于输血治疗SCD的文献。材料和方法:检索PubMed、谷歌Scholar、Scopus、Cochrane等数据库及血液学和输血医学标准文献。搜索中使用的关键词是镰状细胞病、输血、简单和慢性输血、输血并发症、输血血液选择和输血指南。本文对收集到的文献进行了回顾、总结和介绍。结果:输血是SCD患者治疗的基石。SCD患者的管理需要多学科的方法,需要所有专家的大量承诺。虽然许多危险与输血有关,但在血液和血液制品的处理和管理中采取适当的注意是相关的。结论:输血治疗仍然是SCD治疗的基石,它倾向于减轻SCD疾病的严重程度和并发症。专家需要充分的知识和信息,了解输血治疗及其方式在SCD中的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信